| dc.creator |
Ergene, O |
|
| dc.creator |
Ozaydin, M |
|
| dc.creator |
Ergene, U |
|
| dc.creator |
Ucarci, Y |
|
| dc.creator |
Altinbas, A |
|
| dc.creator |
Kinay, O |
|
| dc.creator |
Nazli, C |
|
| dc.creator |
Dogan, A |
|
| dc.creator |
Gedikli, O |
|
| dc.date |
2004-06-01T00:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:19:49Z |
|
| dc.date.available |
2021-12-03T11:19:49Z |
|
| dc.identifier |
3286168b-0061-4e72-bc91-be26912a0bb0 |
|
| dc.identifier |
10.2143/ac.59.3.2005179 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/3286168b-0061-4e72-bc91-be26912a0bb0/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/90780 |
|
| dc.description |
Objective -The aim of this study was to investigate the efficacy and safety of propafenone in the prevention of atrial fibrillation (AF) relapse after restoration of sinus rhythm. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study |
|
| dc.type |
info:eu-repo/semantics/article |
|